KERYX BIOPHARMACEUTICALS INC Current Liabilities
KERYX BIOPHARMACEUTICALS INC had Current Liabilities of $57.10 million as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2018-11-08
- 2018-09-30: Liabilities, Current $57.10M.
- 2018-06-30: Liabilities, Current $55.05M.
- 2018-03-31: Liabilities, Current $44.92M.
- 2017-12-31: Liabilities, Current $45.42M.
| Period end | Liabilities, Current |
|---|---|
| 2018-09-30 | $57.10M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $55.05M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $44.92M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $45.42M 10-Q · filed 2018-11-08 |
| 2017-09-30 | $36.92M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $30.52M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $22.12M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $21.55M 10-K · filed 2018-02-21 |
| 2016-09-30 | $18.28M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $23.41M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $70.08M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $77.61M 10-K · filed 2017-03-01 |
| 2015-09-30 | $30.60M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $27.34M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $36.36M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $29.31M 10-K · filed 2016-02-26 |
| 2014-09-30 | $28.13M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $18.51M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $16.37M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $15.33M 10-K · filed 2015-02-27 |
| 2013-09-30 | $16.50M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $11.82M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $8.66M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $8.04M 10-K · filed 2014-03-13 |
| 2012-09-30 | $7.69M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $9.28M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $9.74M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $9.77M 10-K · filed 2013-03-12 |
| 2011-09-30 | $9.92M 10-Q · filed 2011-11-04 |
| 2011-06-30 | $6.75M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $6.19M 10-K · filed 2012-03-02 |